RVLP Insider Trading Activity and SEC Form 4 Filings
RVLP insider trading summary
No open-market insider purchases or sales of RVL Pharmaceuticals plc (RVLP) have been reported on SEC Form 4 in the past 12 months.
Latest RVLP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 20, 2023 | Orbit Co-Invest A-1 LLC | 10% Owner | Sell | $148K (4,758,899 @ $0.03) |
| Oct 20, 2023 | Altchem Ltd | 10% Owner | Sell | $148K (4,758,899 @ $0.03) |
| Oct 20, 2023 | Harsaul Foundation | 10% Owner | Sell | $148K (4,758,899 @ $0.03) |
| Oct 19, 2023 | Orbit Co-Invest A-1 LLC | 10% Owner | Sell | $432K (9,363,760 @ $0.05) |
| Oct 19, 2023 | Harsaul Foundation | 10% Owner | Sell | $432K (9,363,760 @ $0.05) |
| Oct 19, 2023 | Altchem Ltd | 10% Owner | Sell | $432K (9,363,760 @ $0.05) |
| Oct 18, 2023 | Orbit Co-Invest A-1 LLC | 10% Owner | Sell | $221K (3,421,537 @ $0.06) |
| Oct 18, 2023 | Altchem Ltd | 10% Owner | Sell | $221K (3,421,537 @ $0.06) |
| Oct 18, 2023 | Harsaul Foundation | 10% Owner | Sell | $221K (3,421,537 @ $0.06) |
| Aug 8, 2022 | Avista Healthcare Partners, L.P. | 10% Owner | Buy | $12.4M (8,000,000 @ $1.55) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.